Skyrizi
immunology biologic
1 conceptSkyrizi is AbbVie's IL-23 inhibitor franchise used across plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
ProductsAbbVie
AbbVie product analyses
A tighter look at the products that matter most to AbbVie, along with the free, open, decentralized, or cooperative alternatives already creating pricing pressure and the original disruption concepts that could widen that pressure further.
Products
Where the moat actually touches users
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 2 structured disruption concepts across the current product set.
2 disruption concepts tracked0 documented exceptions
Rinvoq
immunology small-molecule therapy
1 conceptRinvoq is AbbVie's once-daily JAK inhibitor franchise used across multiple immune-mediated inflammatory diseases including rheumatoid arthritis, ulcerative colitis, and Crohn's disease.
Paper trail
Company-level source stack
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
AbbVie Corporate Fact Sheet
AbbVie · investor relations
Official overview of AbbVie's business focus areas, scale, and geographic reach.
Reviewed 2026-03-24
AbbVie 2024 Annual Report on Form 10-K
AbbVie · annual report
Primary source for AbbVie's business mix, strategy, and post-Humira revenue transition.
Reviewed 2026-03-24
AbbVie Market Capitalization
CompaniesMarketCap · market data
Used for March 2026 market cap and approximate ranking context.
Reviewed 2026-03-24